From MarketBeat:

Bio-Techne Co. (NASDAQ:TECH) experienced a significant drop in short interest in January, totalling 4,040,000 shares, a 17.2% decrease from December 31st. With an average trading volume of 1,230,000 shares, the short-interest ratio is currently 3.3 days. Institutional Trading of Bio-Techne included various hedge funds and other institutional investors adjusting their holdings. These investors include Quantbot Technologies LP, Harbour Investments Inc., Exchange Traded Concepts LLC, Huntington National Bank, and Resurgent Financial Advisors LLC, comprising 94.64% of the stock. Analyst ratings announced changes to Bio-Techne, with reports from StockNews.com, UBS Group, TheStreet, and Citigroup. Bio-Techne stock increased by 2.1% as of the latest data. The company had a trading volume of 1,070,572 shares, a market capitalization of $11.49 billion, and a twelve month low and high of $51.79 and $89.91. Bio-Techne last reported earnings with an EPS of $0.35, below consensus estimate, and a return on equity of 14.89%. A quarterly dividend was disclosed and paid on November 24th, with a dividend payout ratio of 21.05%. Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for research and clinical diagnostic markets in the US and internationally.



Read more: Short Interest in Bio-Techne Co. (NASDAQ:TECH) Declines By 17.2%